Recent News View All News

Aug 13, 2025 9:00am EDT

Dogwood Therapeutics Reports Second Quarter 2025 Financial Results

Aug 7, 2025 1:08pm EDT

Dogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up